Please login to the form below

Not currently logged in
Email:
Password:

Ozempic

This page shows the latest Ozempic news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk reveals positive results at ADA 2021 for higher-dose Ozempic in type 2 diabetes

Novo Nordisk reveals positive results at ADA 2021 for higher-dose Ozempic in type 2 diabetes

Ozempic 2 mg demonstrated a 2.2% reduction in blood sugar compared with a 1.9% reduction for those receiving Ozempic 1 mg. ... Drug Administration (FDA), to evaluate the Ozempic 2 mg dose for adults with type 2 diabetes.

Latest news

More from news
Approximately 12 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • NICE – but not enough NICE – but not enough

    Around the same time (late 2018), Novo Nordisk launched Ozempic, also for type 2 diabetes, though a different class (GLP1). ... market. As. you can see, Ozempic – which launched without a NICE TA – outperformed its rival.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
Report: Omnichannel advice for the life science industry
In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...